WO2025133989 - SMYD MODULATORS AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2025/133989
Publication Date
26.06.2025
International Application No.
PCT/IB2024/062924
International Filing Date
19.12.2024
Title **
[English]
SMYD MODULATORS AND USES THEREOF
[French]
MODULATEURS DE SMYD ET LEURS UTILISATIONS
Applicants **
ALT-BIO PTE. LTD.
Inventors
LIU, Jiwen
ZHU, Liusheng
Priority Data
63/612,845
20.12.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 8075 | |
| EPO | Filing, Examination, Granting | 171228 | |
| Japan | Filing, Examination, Granting | 5101 | |
| South Korea | Filing, Examination, Granting | 10768 | |
| USA | Filing, Examination, Granting | 40590 |
Total:
235,762
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure provides compounds or salts of Formula (A), (I) or (II), useful for epigenetic regulation via the modulation of SMYD. In another aspect, the present disclosure provides methods of modulating a SMYD protein via the administration of a compound or salt of Formula (A), (I) or (II), to a subject in need thereof.[French]
La présente divulgation concerne des composés ou des sels de formule (A), (I) ou (II), utiles pour la régulation épigénétique par modulation de SMYD. Selon un autre aspect, la présente divulgation concerne des procédés de modulation d'une protéine SMYD par administration d'un composé ou d'un sel de formule (A), (I) ou (II), à un sujet en ayant besoin.